The Community Oncology Perspective on Drug Pricing Proposals and Biosimilars

Mar 31, 2019, 03:10 AM

The recent weeks and months have seen a number of policy proposals from the Trump administration that impact community oncologists. On this week's podcast, Laura Joszt, associate editorial director of The Center for Biosimilars®, caught up with Ted Okon, MBA, executive director of the Community Oncology Alliance.